文献速递食管胃疾病与幽门螺杆菌消化内镜

小肠胶囊内镜在诊断不明确的乳糜泻中的应用

Use of small-bowel capsule endoscopy in cases of equivocal celiac disease.
PubMed 文献 · Gastrointest Endosc · 2020-01-07

本研究纳入177例十二指肠组织学表现提示诊断不明确的乳糜泻患者,评估小肠胶囊内镜(SBCE)的作用及其诊断时发现能否预测疾病结局。结果显示31.6%患者SBCE阳性,SBCE阳性及病变范围更广与不良结局和生存率降低相关。

要点

  • 对诊断不明确的乳糜泻患者,SBCE诊断时阳性可预测更差结局。
  • SBCE显示小肠病变范围更广与SNVA相关死亡率更高相关。
  • 组织学严重程度与死亡率无关。

核心结论

  • 诊断时SBCE阳性预测更差结局,病变范围更广与生存率低相关。

研究设计与样本

  • 研究纳入177例十二指肠组织学显示SNVA、IELs±隐窝增生且诊断不明确的患者。

主要发现

  • SNVA-UO组SBCE诊断阳性率40.0%(22例),SNVA-CD组51.4%(18例),已知病因组27.0%(10例),IELs±隐窝增生组14.0%(7例)。
  • 在SNVA-UO中,持续SNVA患者SBCE阳性率90.9%(10例),持续SNVA伴淋巴增殖特征者80.4%(4例),均高于自发缓解者20.5%(8例)(P = .0001)。
  • SNVA-CD组中最终发生不良事件者SBCE均阳性(P = .022),且小肠病变范围更广(50% vs 1%,P = .002)。
  • 在SNVA-UO和SNVA-CD患者中,SBCE显示更广泛小肠病变与更高的SNVA相关死亡率相关(P = .019);组织学严重程度与死亡率无关(P = .793)。

临床怎么用

  • 对诊断不明确的乳糜泻患者,可考虑行SBCE以评估病变范围并预测结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Seronegative villous atrophy (SNVA), raised intraepithelial lymphocytes (IELs), and crypt hyperplasia on duodenal histology can be secondary to celiac disease (CD) or other causes such as medications or infections. Our aims were to assess the role of small-bowel capsule endoscopy (SBCE) in these patients and to ascertain whether findings on SBCE at diagnosis can predict disease outcome. METHODS: Patients (n = 177) with SNVA, IELs, ± crypt hyperplasia on duodenal histology were studied. These patients all had an equivocal diagnosis of CD. RESULTS: Overall, 56 patients (31.6%) had a positive SBCE. Thirty-three patients (58.9%) had disease affecting the proximal third of the small bowel (SB). The diagnostic yield of SBCE was 40.0% (22 patients), 51.4% (18 patients), 27.0% (10 patients), and 14.0% (7 patients) in patients with an unknown cause for SNVA (SNVA-UO), patients with SNVA who responded to a gluten-free diet (SNVA-CD), patients with a known cause for SNVA, and patients with railed IELs ± crypt hyperplasia, respectively. In SNVA-UO, SBCE at diagnosis was more likely to be positive in patients with persistent SNVA (10, 90.9%) and persistent SNVA with lymphoproliferative features (4, 80.4%) than patients with spontaneous resolution of SNVA (8, 20.5%) (P = .0001). All patients in the SNVA-CD group who eventually developed adverse events had a positive SBCE (P = .022). They also had more extensive SB disease than those without adverse events (50% vs 1% P = .002). More extensive SB disease on SBCE correlated with a higher SNVA-related mortality in patients with SNVA-UO and SNVA-CD (P = .019). Severity of histology did not correlate with mortality (P = .793). CONCLUSIONS: A positive SBCE at diagnosis predicts a worse outcome. More importantly, more extensive disease in these patients is associated with poor survival. Targeting patients with extensive disease at diagnosis with more aggressive therapy can help to improve prognosis.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Chetcuti Zammit S, Schiepatti A, Aziz I, et al. Use of small-bowel capsule endoscopy in cases of equivocal celiac disease. Gastrointest Endosc. 2020. PMID: 31923404. doi:10.1016/j.gie.2019.12.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。